This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Halozyme Therapeutics Inc (HALO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 27.36M 99.90M 52.83M 83.26M
Receivables 9.10M 15.70M 2.26M 2.33M
Inventories 6.17M 2.67M 567.26K 193.42K
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 95.20M 131.03M 63.99M 89.50M
Property, Plant & Equipment, Gross 11.07M 10.38M 7.52M 6.52M
Accumulated Depreciation & Depletion 7.65M 6.68M 5.75M 4.68M
Property, Plant & Equipment, Net 3.42M 3.70M 1.77M 1.85M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 3.18M 0.00 0.00 0.00
Total Non-Current Assets 6.60M 3.70M 1.77M 1.85M
Liabilities & Shareholder Equity
Total Assets 101.79M 134.73M 65.76M 91.35M
Accounts Payable 3.13M 2.27M 7.56M 3.82M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 25.45M 18.95M 17.30M 15.34M
Long Term Debt 49.77M 29.66M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 474.39K
Other Non-Current Liabilities 46.56M 37.27M 37.56M 55.18M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 96.33M 66.93M 37.56M 55.65M
Total Liabilities 121.78M 85.87M 54.86M 70.99M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -19.99M 48.85M 10.90M 20.35M
Common Par 114.53K 112.71K 103.99K 100.58K
Additional Paid In Capital 361.93M 347.31M 255.82M 245.50M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -382.05M -298.57M -245.02M -225.25M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 17.05K 0.00 0.00 0.00
Total Capitalization 29.78M 78.52M 10.90M 20.35M
Total Equity -19.99M 48.85M 10.90M 20.35M
Total Liabilities & Stock Equity 101.79M 134.73M 65.76M 91.35M
Total Common Shares Outstanding 114.53M 112.71M 103.99M 100.58M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 112.81M 111.08M 102.57M 94.36M
Diluted Weighted Shares Outstanding 112.81M 111.08M 102.57M 94.36M
Number of Employees 170 152 135 102
Number of Part-Time Employees 0 0 0 0
HALO News

HALO Halozyme Therapeutics Inc

Analysts Ratings for HALO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
GET HALO ANALYST REPORT

Brokerage Partners

HALO Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs